Lymphoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed with follicular lymphoma, large B-cell lymphoma (including certain related types), or mantle cell lymphoma, confirmed through standard laboratory testing
• You are scheduled to receive a commercially approved CAR-T cell therapy that matches FDA guidelines for your specific diagnosis, and you must be enrolled in this trial before receiving that treatment
• The CAR-T cell product being used meets the manufacturer's required standards
• Your disease is visible and measurable on a PET scan at the time your doctor decides to prescribe CAR-T therapy
• A tissue sample from either your original diagnosis or a later relapse is available, so that a specific marker unique to your cancer cells (called a "clonotype") can be identified through a test called clonoSEQ

Who may not be able to join:

• If no stored or fresh tissue sample from your diagnosis or relapse is available to identify your cancer's unique marker, you may not be eligible
• If the laboratory test (clonoSEQ) is unable to identify your cancer's unique marker from your sample, you would be removed from the study (note: this happens in roughly 5–10% of cases — confirm with trial site)

Who will not be excluded:

• No one will be turned away based on gender, race, ethnic background, sexual orientation, or other personal characteristics

Important: Always verify eligibility with the trial site directly before applying.